Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNONW) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to $3.8 million.

  • Tenon Medical's Non-Current Assets rose 10642.9% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year decrease of 249.55%. This contributed to the annual value of $1.6 million for FY2024, which is 3350.98% down from last year.
  • As of Q3 2025, Tenon Medical's Non-Current Assets stood at $3.8 million, which was up 10642.9% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Tenon Medical's Non-Current Assets registered a high of $3.8 million during Q3 2025, and its lowest value of $1.2 million during Q2 2025.
  • For the 5-year period, Tenon Medical's Non-Current Assets averaged around $1.9 million, with its median value being $1.8 million (2022).
  • Data for Tenon Medical's Non-Current Assets shows a peak YoY increase of 10642.9% (in 2025) and a maximum YoY decrease of 3590.41% (in 2025) over the last 5 years.
  • Over the past 5 years, Tenon Medical's Non-Current Assets (Quarter) stood at $1.6 million in 2021, then grew by 8.88% to $1.7 million in 2022, then surged by 40.99% to $2.5 million in 2023, then crashed by 33.51% to $1.6 million in 2024, then surged by 133.99% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $1.2 million for Q2 2025, and $1.4 million during Q1 2025.